Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. This is a 57.14 percent increase over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $14.22 million which beat the analyst consensus estimate of $13.39 million by 6.21 percent. This is a 3.01 percent decrease over sales of $14.66 million the same period last year.